Cotecna, a leading provider of Testing, Inspection and Certification services, announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certified analytical testing laboratory based in Hyderabad, India. The move significantly strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors.
The acquisition matters because India is one of the world's fastest-growing pharmaceutical markets and a critical manufacturing hub for global healthcare supply chains. By acquiring Energon, Cotecna gains access to highly specialized scientific talent, advanced laboratory infrastructure, and a well-established pharmaceutical ecosystem in Hyderabad, one of the world's leading pharmaceutical and biotechnology hubs. This enhances Cotecna's ability to support both Indian and international customers with high-quality, regulatory-compliant testing services while delivering greater responsiveness, scalability, and operational efficiency across key markets.
Energon serves customers across India, the United States, Asia-Pacific, and the Middle East and is recognized for its scientific excellence, regulatory expertise, and commitment to quality. Its comprehensive portfolio of analytical testing and quality assurance services includes analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptides and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services. These capabilities complement Cotecna's growing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals, and Neotron Pharma, strengthening the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance, and regulatory requirements.
Sebastien Dannaud, Chief Executive Officer of Cotecna Group, said: “We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India, and strengthens our position in one of the world's most important pharmaceutical markets.” Amit Chopra, CEO South Asia and Middle East, Cotecna Group, added: "This acquisition aligns perfectly with our strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets. Energon's strong technical capabilities, experienced team and established customer relationships will enhance our ability to serve pharmaceutical, biopharmaceutical and medical device companies across India and globally." Manikanth Reddy, Founder of Energon, said: "Joining the Cotecna Group opens an exciting new chapter for Energon Labs. Becoming part of a global organization like Cotecna provides new opportunities to expand our capabilities, strengthen our service offerings and deliver even greater value to our customers."
The deal underscores Cotecna's strategic focus on expanding its life sciences footprint in high-growth markets and positions the company to better serve pharmaceutical manufacturers facing increasingly complex regulatory demands. The original release is available via www.newmediawire.com.
